These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 1974168
1. p185neu expression in human lung adenocarcinomas predicts shortened survival. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. Cancer Res; 1990 Aug 15; 50(16):5184-7. PubMed ID: 1974168 [Abstract] [Full Text] [Related]
2. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, Kern JA. Cancer Res; 1990 Jan 15; 50(2):421-5. PubMed ID: 1967224 [Abstract] [Full Text] [Related]
3. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y. Rinsho Byori; 1996 Jan 15; 44(1):32-41. PubMed ID: 8691638 [Abstract] [Full Text] [Related]
4. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire HC, LiVolsi VA, Greene MI. Oncogene; 1989 Jan 15; 4(1):81-8. PubMed ID: 2563577 [Abstract] [Full Text] [Related]
5. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors. Pavelic K, Antonic M, Pavelic L, Pavelic J, Pavelic Z, Spaventi S. Anticancer Res; 1992 Jan 15; 12(6B):2191-6. PubMed ID: 1363516 [Abstract] [Full Text] [Related]
6. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Yu D, Wang SS, Dulski KM, Tsai CM, Nicolson GL, Hung MC. Cancer Res; 1994 Jun 15; 54(12):3260-6. PubMed ID: 7911396 [Abstract] [Full Text] [Related]
7. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. Kern JA, Slebos RJ, Top B, Rodenhuis S, Lager D, Robinson RA, Weiner D, Schwartz DA. J Clin Invest; 1994 Feb 15; 93(2):516-20. PubMed ID: 7906694 [Abstract] [Full Text] [Related]
8. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Motojima K, Furui J, Kohara N, Izawa K, Kanematsu T, Shiku H. Surgery; 1994 Mar 15; 115(3):349-54. PubMed ID: 7907434 [Abstract] [Full Text] [Related]
9. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT. Mod Pathol; 1997 Feb 15; 10(2):142-8. PubMed ID: 9127320 [Abstract] [Full Text] [Related]
10. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P. Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640 [Abstract] [Full Text] [Related]
11. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ. Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470 [Abstract] [Full Text] [Related]
12. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG. Oncogene; 2003 Sep 11; 22(39):7950-7. PubMed ID: 12970743 [Abstract] [Full Text] [Related]
13. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W. Hum Pathol; 2008 Jan 11; 39(1):126-36. PubMed ID: 17949785 [Abstract] [Full Text] [Related]
14. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas. Liu C, Tsao MS. Am J Pathol; 1993 Apr 11; 142(4):1155-62. PubMed ID: 8097369 [Abstract] [Full Text] [Related]
15. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep 11; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
16. Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance. Tomiyasu M, Yoshino I, Suemitsu R, Okamoto T, Sugimachi K. Clin Cancer Res; 2002 Dec 11; 8(12):3755-60. PubMed ID: 12473586 [Abstract] [Full Text] [Related]
17. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY. Cancer Genet Cytogenet; 2007 Mar 11; 173(2):107-13. PubMed ID: 17321325 [Abstract] [Full Text] [Related]
18. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS. Oncol Rep; 2006 Dec 11; 16(6):1205-10. PubMed ID: 17089038 [Abstract] [Full Text] [Related]
19. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype. Volm M, Koomägi R, Efferth T, Mattern J. Anticancer Res; 2002 Dec 11; 22(4):2321-4. PubMed ID: 12174921 [Abstract] [Full Text] [Related]
20. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M, Mattern J. Anticancer Res; 1993 Dec 11; 13(6A):2021-5. PubMed ID: 8297109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]